American Heart Association
American Heart Association
November 24, 2018
5 min watch
Save

VIDEO: CV effects of vitamin D, omega-3 supplements remain unclear

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — In this video exclusive, JoAnn E. Manson, MD, DrPH, FAHA, highlights results of the large-scale VITAL trial, which analyzed omega-3 and vitamin D supplementation for primary prevention of CVD and cancer.

While supplementation did not result in a lower incidence of major CV events or cancer compared with placebo over 5 years of follow-up, several findings of note emerged in secondary and subgroup analyses, according to Manson, a professor of medicine at Harvard Medical School and chief of the division of preventive medicine at Brigham and Women’s Hospital.

Manson also discusses clinical implications of the VITAL data and further analyses that are underway, including supplementation for cognitive function, diabetes and autoimmune diseases.

Watch the video for more.